Exicure (XCUR) Other financing activities (2016 - 2022)
Exicure's (XCUR) quarterly Other financing activities came in at -$9000.0 in Q4 2022, down 212.5% YoY from $8000.0 in Q4 2021, and down 190.0% on a QoQ basis from $10000.0 in Q3 2022.
Exicure (XCUR) Other financing activities (2016 - 2022) Analysis & Trends
Exicure (XCUR) has 7 years of Other financing activities data on file, last reported at -$9000.0 in Q4 2022.
- Quarterly Other financing activities fell 212.5% year-over-year to -$9000.0 in Q4 2022, while the trailing twelve-month figure through Sep 2023 was -$9000.0 (down 140.91% YoY) and the FY2022 annual result came in at $5000.0, down 37.5% from the prior year.
- Other financing activities retreated to -$9000.0 in Q4 2022, from $10000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $546000.0 in Q1 2021 to a low of -$415000.0 in Q2 2021.
- A 5-year average of $35428.6 and a median of $12000.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2020 — Other financing activities soared 413.79% — and 2021, when it slumped 289.86%.
- Tracing XCUR's Other financing activities over 5 years: stood at $34000.0 in 2018, then surged by 70.59% to $58000.0 in 2019, then soared by 413.79% to $298000.0 in 2020, then plunged by 97.32% to $8000.0 in 2021, then tumbled by 212.5% to -$9000.0 in 2022.
- The last three Other financing activities figures came in at -$9000.0 (Q4 2022), $10000.0 (Q3 2022), and -$10000.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -9,000.00 |
| Dec 31, 2022 | -9,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Jun 30, 2022 | -10,000.00 |
| Jun 30, 2022 | -10,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | -131,000.00 |
| Sep 30, 2021 | -131,000.00 |
| Jun 30, 2021 | -415,000.00 |
| Jun 30, 2021 | -415,000.00 |
| Mar 31, 2021 | 546,000.00 |
| Mar 31, 2021 | 546,000.00 |
| Dec 31, 2020 | 298,000.00 |
| Dec 31, 2020 | 298,000.00 |
| Sep 30, 2020 | 69,000.00 |
| Sep 30, 2020 | 69,000.00 |